ENFORCEMENT EVIDENCE · VERIFIED 03 OCT 2026

Creatine malate in the EU: September 2026 enforcement actions

Novel Food status and action against named products are different evidence. Check the exact form, product, market and notice scope—without extending a finding to all creatine products.

LEGAL STATUS EVIDENCE ≠ ENFORCEMENT OBSERVED

Creatine monohydrate is not creatine malate.

The Commission's published Article 4 consultation outcomes distinguish these forms. The specified micronised monohydrate is not novel; the malate and alpha-ketoglutarate consultation considers those forms novel in foods. A conclusion does not transfer to a different salt, blend or process.

Monohydrate consultation ↗ · Malate and alpha-ketoglutarate consultation ↗

ENF

ENFORCEMENT OBSERVED · MT / GR

Observed enforcement activity

Separate event evidence, checked 3 October 2026. This does not refresh the earlier legal-status or claim-condition check. Original authority text takes precedence over summaries and translations.

GR · DISTRIBUTION PROHIBITION

National Organisation for Medicines (EOF) · 113393

CM3 CAPS; CM3 POWDER 250G PINK GRAPEFRUIT

Authority-stated reason: unauthorised Novel Food creatine malate.

Distribution prohibition for named products. Lot numbers, best-before dates and EANs are not specified in the decision; Malta's scope is not transplanted.

Original source (el) ↗
GR · DISTRIBUTION PROHIBITION

National Organisation for Medicines (EOF) · 115544

Redweiler 480g Red Punch; Redweiler 480g Orange; Redweiler 480g Cola; TCM 120 MEGA caps

Authority-stated reason: unauthorised Novel Food creatine malate.

Distribution prohibition for named products. Lot numbers, best-before dates and EANs are not specified in the decision; Malta's scope is not transplanted.

Original source (el) ↗
MT · CONSUMER WARNING

Food Safety and Security Authority · PR261551en

Redweiler 480g Red Punch; Redweiler 480g Orange; Redweiler 480g Cola

Authority-stated reason: unauthorised Novel Food creatine malate.

All lots and all best-before dates of the named products. Consumer warning.

Original source (en) ↗

SV-ENF-CRE-2026.10.03 · RASFF: linkage reported by the authorities; no direct notification record or ID verified. Point-in-time registry, not live monitoring. A form match still needs product, material, market and notice-scope confirmation.

PRODUCT SCOPE → PORTFOLIO REVIEW

What should an enforcement signal trigger?

  1. Compare the full form name in the formula and current spec. Generic creatine or an acronym does not establish identity.
  2. Verify product, EAN, lot scope, market and any later decision changes. The same ingredient in a different SKU is a review signal, not automatic inclusion in a prohibition.
  3. Check distributors, stock, marketplaces and public offers. Form counts below are declarations, not crawler findings.
  4. Record the operational decision and change evidence in your own system. A working note does not close a case or execute a withdrawal.
ENFORCEMENT EVIDENCE · POINT-IN-TIME

Check whether your exact creatine form is affected

Three MT/GR events checked 3 October 2026. Up to 20 SKU declarations from a formula or supplier spec. No upload, persistence or live page checks.

Declared portfolio

SKU 1

Product, stock and surface (optional)
NO AUTOMATIC VERDICT

Monohydrate ≠ malate.

Full form names are compared with a curated alias dictionary. Generic creatine, TCM, CM3 and underspecified blends need identity review.

Connect the form to the existing ingredient profile

This adds event evidence, not a duplicate creatine legal rule.

Creatine evidence profile ↗

Bounded public preview. No automatic feeds, persistent portfolio, verified public snapshots or distribution actions. Original notices remain decision sources; translation is context.